[6,6-2H2]glucose
NL73191.042.20
Phase 2 mab completed
Quick answer
[6,6-2H2]glucose for Glycogen Storage Disease Type IA is a Phase 2 program (mab) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ultragenyx Pharmaceutical
- Indication
- Glycogen Storage Disease Type IA
- Phase
- Phase 2
- Modality
- mab
- Status
- completed